Safety, immunogenicity and efficacy after switching from reference infliximab to biosimilar SB2 compared with continuing reference infliximab and SB2 in patients with rheumatoid arthritis: results of a randomised, double-blind, phase III transition s
| Image |  |
|---|---|
| Description | scientific article published on 17 October 2017 |
| Author/s |
author: Sofia Ramiro Roman Yatsyshyn |
| Publication date | October 17, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |